Eli Lilly And Co (NYSE:LLY) Commences First Human Trial Involving Its Antibody-based COVID-19 Treatment

Eli Lilly And Co (NYSE:LLY) revealed on Monday that it started testing human subjects with its developmental treatment for COVID-19, which is based on antibodies. The biopharma is currently working on phase 1 of the clinical trial, through which it aims to test the safety and efficacy of the drug. Eli Lilly plans to publish […]

The Incyte Rheumatoid Arthritis Pill Setback Poses Disagreements With FDA, As Pfizer Inc (NYSE:PFE) And Others Stand To Gain

The recent turn of events in some of the top stocks have raised eyebrows worldwide, but what Eli Lilly and Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) have become the highest talk cutting through the air! The two chose Friday, which as a matter of fact happens to be a market holiday to actually disclose the […]

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) Presents Interesting Picture as a Bite-Size Buyout Candidate

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) is in an interesting phase of its existence. The company just solidified its sense of credibility in the space with a recent announcement of a productive meeting with top staffing scientists at the host hospital of the Company’s upcoming Phase 2 trial of ProscaVax for prostate cancer. That represents the first […]

Insulin Drug By Eli Lilly And Co (NYSE:LLY) Performs Better Than Lantus From Sanofi SA (ADR) (NYSE:SNY) In Trials

Eli Lilly and Co (NYSE:LLY) has a reason to celebrate as their insulin drug registered better results than the current top-selling drug called Lantus that was developed by Sanofi SA (ADR) (NYSE:SNY). Lilly’s insulin recorded better results in terms of blood sugar reduction for type two diabetes compared to Lantus. The data was collected from […]

Amgen, Inc. (NASDAQ:AMGN) Migraine Treatment Drug Passes Phase 2 Trials

In a breakthrough in migraine treatment, the Phase 2 results of the clinical trials of AMG 334 drug by Amgen, Inc. (NASDAQ:AMGN) has been successful. Competing with the existing migraine drugs, the monthly rates of migraine attacks were comparably less when using this medication. According to the company, the AMG 334 drug lowered the chance […]

Transition Therapeutics Inc (USA) (NASDAQ:TTHI) And Eli Lilly and Co (NYSE:LLY) Enter A $100 Million Partnership For Muscle Drug

Transition Therapeutics Inc (USA) (NASDAQ:TTHI) and Eli Lilly and Co (NYSE:LLY) have entered a new collaboration worth $100 million in exchange of full rights to develop and promote the muscle-building drug TT701. Eli Lilly would be giving the company the TT701 drug candidate that shows the possibility of augmenting the body mass and strength. The […]

Eli Lilly and Co (NYSE:LLY) Opens a Facility At Cambridge

Eli Lilly and Co (NYSE:LLY) is looking to Cambridge to jump start its innovation engine. The company will be building a new R&D facility on the Charles River becoming the latest company to make the move. The new facility is named Lilly Cambridge Innovation Center and will start by the end of the year Kendall […]

Celgene Corporation (NASDAQ:CELG) to buy Cancer research Company Quanticel Pharmaceuticals

Celgene Corporation (NASDAQ:CELG) is buying up Quanticel Pharmaceuticals for a deal worth $485 million. The deal comes after Clegene teamed up with Versant Ventures to help Quanticel get off the ground Quanticel is a cancer focused biotech and has a drug recover engine that uses single cell genomic analysis to decode cancer cells and highlight […]

Eli Lilly and Co (NYSE:LLY) Discontinues The Development of Tabalumab On The Basis of Phase 3 Lupus Studies

Boston, MA 10/03/2014 (wallstreetpr) – According to reports, Eli Lilly and Co (NYSE:LLY) has decided to stop the development of Tabalumab. It was in phase three Lupus Studies at the time of discontinuation of the production. Insights of this decision: As per the information, Eli Lilly and Co (NYSE:LLY) had Tabalumab in order to study the treatment […]

Major Movers: Spectra Energy (SE), Eli Lilly and Co (LLY), Sino-Global Shipping America (SINO), Digital Power (DPW)

Denver, CO, 09/16/2014, (Avauncer.com) – Spectra Energy Corp. (NYSE:SE), Spectra Energy Partners (NYSE:SEP) and Northeast Utilities (NYSE:NU) announced the details of their natural gas project known as Access Northeast. The project aims to meet the increasing demand for natural gas in New England. The companies said the project will guarantee daily natural gas supplies to […]

AstraZeneca plc (ADR) (NYSE:AZN) To Enter Into Partnership With Eli Lilly and Co (NYSE:LLY) On Alzheimer’s Drug

Boston, MA 09/16/2014 (wallstreetpr) – According to reports, AstraZeneca plc (ADR) (NYSE:AZN) has decided to enter into a partnership with Eli Lilly and Co (NYSE:LLY) in order to ensure a smooth development of Alzheimer’s drug. The deal will cost around $500 million to AZN. As per the information, British Group had decided to come up […]

Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPYY) And Eli Lilly and Co (NYSE:LLY) Lose Their Way To Throw Out $9 Billion Claims

Boston, MA 08/29/2014 (wallstreetpr) – Pharmaceutical companies Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPYY) and Eli Lilly and Co (NYSE:LLY) have lost their way in bringing back the case in its favor in a $9 billion damage award for covering up the cancer risks related with their diabetes drug, Actos. Punitive Damages A U.S. District Court Judge […]

Eli Lilly and Co (NYSE:LLY) Gets FDA Tentative Approval for Diabetes Drug

Boston, MA 08/19/2014 (wallstreetpr) – Eli Lilly and Co (NYSE:LLY) received positive news on its insulin injection that can be used to control sugar levels in diabetic patients after the FDA granted it tentative approval. The drug named, Basaglar, can be used to provide long lasting blood sugar control when patients are taking their meals […]

EMC Corporation (NYSE:EMC) Facing Competition With Storage Equipment Technology’s Speeding Advancement

Boston, MA 06/17/2014 (wallstreetpr) – EMC Corporation (NYSE:EMC) faces increased competition from recent startups as the data storage equipment technology continues to expand. Competition From Startups Analysts have been marking the increasing competition that the industry’s market share leader EMC Corporation (NYSE:EMC) is facing as new startups continue to progress rapidly advancing in technology breakthroughs. […]